Please use this identifier to cite or link to this item: http://imsear.hellis.org/handle/123456789/70511
Title: Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin.
Authors: Kumar, A
Tewari, H K
Bathwal, D P
Khosla, P K
Issue Date: 1-Mar-1994
Citation: Kumar A, Tewari HK, Bathwal DP, Khosla PK. Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin. Indian Journal of Ophthalmology. 1994 Mar; 42(1): 31-5
Abstract: Proliferative vitreoretinopathy (PVR) remains the most common cause of failure in retinal detachment surgery. Surgical procedures for its repair entails complex and extensive instrumentation besides technical skill. The success rate varies widely with high incidence of redetachment. Keeping this in view, we evaluated the role of intravitreal daunorubicin as an anti-mitiotic agent in the inhibition of PVR. Our study concluded that 5 micrograms of intravitreal daunorubicin effectively inhibited PVR in the rabbit eye and the dosage was safe and nontoxic. The half-life of the drug was determined to be about 140 minutes, suggesting a prolonged intravitreal concentration sufficient to prevent fibroblast proliferation.
URI: http://imsear.hellis.org/handle/123456789/70511
Appears in Collections:Indian Journal of Ophthalmology

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.